Grifols SA (GRFS) ADR each Representing 1 Non Voting B Share
1.10%- This stock can be held in a
Stocks and Shares ISA
$0.01
(0.07%)$0.01
(0.07%)Company Information
About this company
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
Key people
Key facts
- EPICGRF
- LocationSpain
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINUS3984384087
- Market cap$6.00bn
- Employees23,833
- Shares in issue426.13m
- ExchangeMercado Continuo Espana
- IndexIBEX 35 Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.